Zoetis Inc. Defined Contribution Plan, Cost
Zoetis Inc. (ZTS) reported Defined Contribution Plan, Cost of $77.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2026-02-12
- Zoetis Inc. defined contribution plan, cost for fiscal 2025 was $77.00M, a 2.53% decline from fiscal 2024.
- Zoetis Inc. defined contribution plan, cost for fiscal 2024 was $79.00M, a 14.49% increase from fiscal 2023.
- Zoetis Inc. defined contribution plan, cost for fiscal 2023 was $69.00M, a 21.05% increase from fiscal 2022.
- Zoetis Inc. defined contribution plan, cost for fiscal 2022 was $57.00M, a 5.56% increase from fiscal 2021.
| Period end | Defined Contribution Plan, Cost 12 month |
|---|---|
| 2025-12-31 | $77.00M 10-K · filed 2026-02-12 |
| 2024-12-31 | $79.00M 10-K · filed 2026-02-12 |
| 2023-12-31 | $69.00M 10-K · filed 2026-02-12 |
| 2022-12-31 | $57.00M 10-K · filed 2025-02-13 |
| 2021-12-31 | $54.00M 10-K · filed 2024-02-13 |
| 2020-12-31 | $48.00M 10-K · filed 2023-02-14 |
| 2019-12-31 | $46.00M 10-K · filed 2022-02-15 |
| 2018-12-31 | $43.00M 10-K · filed 2021-02-16 |
| 2017-12-31 | $38.00M 10-K · filed 2020-02-13 |
| 2016-12-31 | $40.00M 10-K · filed 2019-02-14 |
| 2015-12-31 | $43.00M 10-K · filed 2018-02-15 |
| 2014-12-31 | $38.00M 10-K · filed 2017-02-16 |
| 2013-12-31 | $35.00M 10-K · filed 2016-02-24 |
| 2012-12-31 | $20.00M 10-K · filed 2015-02-27 |
| 2011-12-31 | $18.00M 10-K · filed 2014-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |